ARCHIVES

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

ACS Executive Proposes Efficiency Plan, Critics Fear Erosion Of Local Influence

May 1, 1998

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013

Congress to hold hearings on NIH ethics, Zerhouni pledges greater transparency.

January 9, 2004

Includes Sept. Business & Regulatory Report.

September 26, 2003

Blacks Half As Likely To Get Surgery For Esophageal Cancer

January 28, 2005

In Brief: Rhoads Renamed Cancer Advisory Board Chairman; L-B’s Frederick Contract Renewed For $12 Million

June 28, 1974